文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

作者信息

Piert Morand, Machulla Hans-Jürgen, Picchio Maria, Reischl Gerald, Ziegler Sybille, Kumar Piyush, Wester Hans-Jürgen, Beck Roswitha, McEwan Alexander J B, Wiebe Leonard I, Schwaiger Markus

机构信息

Nuclear Medicine Clinic, Technical University of Munich, Munich, Germany.

出版信息

J Nucl Med. 2005 Jan;46(1):106-13.


DOI:
PMID:15632040
Abstract

UNLABELLED: The study was performed to compare the (18)F-labeled nitroimidazole compound fluoroazomycin arabinoside ((18)F-FAZA) with the standard hypoxia tracer fluoromisonidazole ((18)F-FMISO) in detection of tumor tissue hypoxia and to verify the oxygenation dependency of (18)F-FAZA uptake. METHODS: Biodistribution of (18)F-FAZA was studied at various time points in EMT6 tumor-bearing BALB/c mice and in AR42J and A431 tumor-bearing nude mice and compared with that of (18)F-FMISO. The presence of tumor tissue hypoxia was verified in 5 EMT6 and 5 AR42J tumors using an oxygen-sensing needle electrode system. To evaluate the oxygenation dependency of (18)F-FAZA uptake, using the Munich prototype animal PET scanner, 2 serial PET scans were performed in 13 A431 tumor-bearing nude mice breathing pure oxygen or room air on 1 d and then selecting the other oxygen breathing condition on the following day. In addition, digital autoradiography was performed with EMT6 tumor-bearing (18)F-FAZA-dosed, nude mice breathing either room air (n = 8) or carbogen (n = 9). RESULTS: Tissue partial pressure of oxygen (Po(2)) electrode measurements revealed that tumor hypoxia was present under room air breathing in EMT6 (tissue Po(2) = 2.9 +/- 2.6) and AR42J tumors (tissue Po(2) = 0.4 +/- 0.2), which was significantly lower compared with that of reference tissue (tissue Po(2) = 25.8 +/- 6.7 and tissue Po(2) = 29.0 +/- 3.0 [mean +/- SD], respectively; P < 0.01). In all tumor models, (18)F-FAZA displayed significantly higher tumor-to-muscle and tumor-to-blood ratios compared with (18)F-FMISO, indicating a faster clearance of (18)F-FAZA from normal tissues. In AR42J tumors, (18)F-FAZA tumor-to-normal ratios were found to increase over time. Serial animal (18)F-FAZA PET studies showed that the tumor-to-background ratio was significantly higher in animals breathing room air compared with that of animals breathing pure oxygen (7.3 +/- 2.3 vs. 4.2 +/- 1.2, respectively; P < 0.001). Similarly, autoradiography showed significantly higher tumor-to-muscle ratios in mice breathing room air compared with those of animals breathing carbogen (5.3 +/- 0.8 vs. 2.2 +/- 0.8; respectively; P < 0.02). CONCLUSION: (18)F-FAZA shows superior biokinetics and is, thus, a promising PET tracer for the visualization of tumor hypoxia. This study also verified a hypoxia-specific uptake mechanism for (18)F-FAZA in murine tumor models.

摘要

相似文献

[1]
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

J Nucl Med. 2005-1

[2]
Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

J Pharm Pharm Sci. 2007

[3]
Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.

Eur J Nucl Med Mol Imaging. 2004-1

[4]
A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.

Int J Radiat Oncol Biol Phys. 2014-12-6

[5]
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.

J Nucl Med. 2008-4

[6]
Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).

Radiat Oncol. 2011-11-25

[7]
Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.

Radiother Oncol. 2006-8

[8]
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.

Eur J Nucl Med Mol Imaging. 2004-4

[9]
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.

J Nucl Med. 2013-5-22

[10]
Comparison of three F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [F]FBNA, [F]FAZA and [F]FMISO.

Nucl Med Biol. 2023

引用本文的文献

[1]
Hypoxia Imaging in Lung Cancer: A PET-Based Narrative Review for Clinicians and Researchers.

Pharmaceuticals (Basel). 2025-3-25

[2]
PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach.

Front Nucl Med. 2023-2-27

[3]
Equivalent uniform aerobic dose in radiotherapy for hypoxic tumors.

Phys Med Biol. 2024-4-3

[4]
Concomitant [F]F-FAZA and [F]F-FDG Imaging of Gynecological Cancer Xenografts: Insight into Tumor Hypoxia.

In Vivo. 2024

[5]
Recent Advances of Ga-Labeled PET Radiotracers with Nitroimidazole in the Diagnosis of Hypoxia Tumors.

Int J Mol Sci. 2023-6-23

[6]
Kinetic Evaluation of the Hypoxia Radiotracers [F]FMISO and [F]FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging.

Nucl Med Mol Imaging. 2023-2

[7]
Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis.

Int J Mol Sci. 2022-12-13

[8]
Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose.

Front Med (Lausanne). 2022-10-5

[9]
Hypoxia-Inducible Factors and Diabetic Kidney Disease-How Deep Can We Go?

Int J Mol Sci. 2022-9-8

[10]
FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer.

J Pers Med. 2022-7-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索